drugset / Trial / NCT00444665

Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy

NCT00444665

Phase 4 Completed 750 enrolled Alcon Research
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Examine the safety, tolerability and efficacy of travoprost benzalkonium chloride (BAK) free ophthalmic solution compared to either latanoprost or bimatoprost monotherapy.

Timeline

Start
2007-05
Primary completion
2007-08
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Travoprost Other / unclassified

Indications